Made in China 2025

China’s KET development; how does it compare to the Netherlands?

Netherlands Innovation Network Academics, High Tech Systems and Materials, Life Sciences & Health Leave a Comment

How to deal with China on technologies where Europe has an edge has become an important facet to strategic engagement. This is especially true of key enabling technologies where China has proclaimed in its Made In China 2025 and Strategic Emerging Industry plans that it wants to be more self-sufficient. But how big is the perceived knowledge gap really? Within …

Nanomedicine as a Key Enabling Technology

Claire Selbeck Life Sciences & Health Leave a Comment

The 2018-2021 Knowledge and Innovation Agenda, presented by the Ministry of Economic Affairs and Climate Policy outlines societal challenges and Key Enabling Technologies. Societal challenges cover the scope of health, climate, energy, and agri-food. There are ten clusters of KETs in total, ranging from nanotechnologies, advanced materials, technologies in life sciences and quantum. Each cluster has specific technologies which can …

Demographic and healthcare vulnerabilities driving health tech developments

Netherlands Innovation Network Life Sciences & Health Leave a Comment

If current trends continue, by 2029 China’s population will peak at 1.44 billion, with dramatically imbalanced ratios of young to old (4 grandparents, 2 parents, 1 child) putting unprecedented pressure on younger generations. This dependency ratio (non-working: working people) is set to increase from 42% to 67% by 2050, by when a quarter of the Chinese population (350 million) will …

China’s Vaccine Program and mRNA Technology

Netherlands Innovation Network Life Sciences & Health Leave a Comment

Globally, a process of immunization has started. The first Covid-19 vaccines have been approved by national and regional medicinal drug supervisors such as the UK MHRA, US FDA, and the EU EMA (The Economist, 2020). The Netherlands does not have a big biotech/pharma company (anymore) and is therefore not a leading contender in vaccine production.  Traditionally, vaccines put (a part …

Interview with Wang Yiding

Netherlands Innovation Network Academics, Interviews, Life Sciences & Health Leave a Comment

by Claire Selbeck Mr Wang is an alumnus of two Dutch universities; Wageningen University and the Delft University of Technology. In the past, he has worked at Sinovac and he currently works at Pfizer, as the Senior Manager Vaccine GCMC China. In Beijing, the Innovation Network had the opportunity to meet with him and hear more about his studies in …

Cleveringa Lecture in Shanghai about the pharmaceutical industry

Netherlands Innovation Network Academics, Life Sciences & Health Leave a Comment

The Netherlands Innovation Network China organized their yearly Cleveringa Lecture at the residence of the Consulate-General in Shanghai. The lecture was given by Henk Jan Out, writer of the book ‘Long Live the Medicine’ (Lang leve het Geneesmiddel) and CSO of Ferring Pharmaceuticals in Shanghai. The topic of his lecture was “Pharmaceutical Companies: Creative Innovators or Crooked Moneymakers?” and was …

#2 Antimicrobial Resistance (AMR) – 3 innovative scientific approaches

Netherlands Innovation Network Life Sciences & Health, Podcast Leave a Comment

The world is fighting two pandemics at the same time – COVID19 and the silent pandemic of antimicrobial resistance (AMR). AMR occurs when bacteria become resistant to antibiotics, making their infections harder to treat. In Europe, approximately 25.000 people die every year because of drug resistant infections. It is estimated that AMR will kill an extra 10 million people globally by 2050. In this episode we …

#1 Antimicrobial Resistance (AMR) – introduction from CN and NL

Netherlands Innovation Network Life Sciences & Health, Podcast 1 Comment

The world is fighting two pandemics at the same time – COVID19 and the silent pandemic of antimicrobial resistance (AMR). AMR occurs when bacteria become resistant to antibiotics, making their infections harder to treat. In Europe, approximately 25.000 people die every year because of drug resistant infections. It is estimated that AMR will kill an extra 10 million people globally by 2050. In this episode we …

Life Sciences and Health webinar

Netherlands Innovation Network Life Sciences & Health, Sino-Dutch collaboration Leave a Comment

Nuffic Neso China, the representative office of Dutch higher education in China, is organizing the Orange Expert Webinar of Studying and Doing Research in the Netherlands with a focus on life sciences and health. The Science & Technology Counsellor at the Embassy of the Netherlands, Taake Manning, will open the webinar and will give an introduction to the life sciences …

Augmented AI for future disease surveillance: how AI can help prevent future pandemics

Netherlands Innovation Network Life Sciences & Health Leave a Comment

Emerging pathogens are a major threat to the public health. Over the past decades many scientists have warned us about new conditions that could lead to the introduction of new, potentially devastating pathogens. Despite the warnings, it is clear humans have failed to respond adequately to the pandemic which started in China in December 2019 infecting at the time of …